ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

Hayloc, Krebs Lead Oncology Nurses

May 16, 1997

HEW Says Patent Delays Temporary

August 25, 1978

Paul Okunieff Named Director At UF Shands Cancer Center

October 16, 2009

Henry Kaplan Was One Of The Century’s Top Scientists, DeVita Says

March 23, 1984

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993